Cargando…

Impact of hepatic function on serum procalcitonin for the diagnosis of bacterial infections in patients with chronic liver disease: A retrospective analysis of 324 cases

Although procalcitonin (PCT) is a valid marker for early diagnosis of bacterial infections, it is unclear whether its accuracy in predicting bacterial infections is affected by impaired liver function. This study aimed to assess the impact of compromised liver function on the diagnostic value of PCT...

Descripción completa

Detalles Bibliográficos
Autores principales: Qu, Junyan, Feng, Ping, Luo, Yan, Lü, Xiaoju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5265836/
https://www.ncbi.nlm.nih.gov/pubmed/27472699
http://dx.doi.org/10.1097/MD.0000000000004270
_version_ 1782500347060682752
author Qu, Junyan
Feng, Ping
Luo, Yan
Lü, Xiaoju
author_facet Qu, Junyan
Feng, Ping
Luo, Yan
Lü, Xiaoju
author_sort Qu, Junyan
collection PubMed
description Although procalcitonin (PCT) is a valid marker for early diagnosis of bacterial infections, it is unclear whether its accuracy in predicting bacterial infections is affected by impaired liver function. This study aimed to assess the impact of compromised liver function on the diagnostic value of PCT. This retrospective study was conducted between January 2013 and May 2015. A total of 324 patients with chronic liver disease were enrolled. Routine laboratory measurements and PCT were performed. Patients were divided into 3 groups according to clinical diagnosis: chronic hepatitis (group 1), decompensated cirrhosis (group 2), and acute-on-chronic liver failure/chronic liver failure (group 3). The correlation between PCT and liver function was analyzed. The area under the receiver operating characteristic (AUCROC) curve of PCT was analyzed according to infection status and liver function. PCT was more accurate than white blood cell count (P < 0.001) and percentage of neutrophils (P < 0.001) in detecting bacterial infections in patients with impaired liver function. In patients without infection, PCT had a moderate positive correlation with serum total bilirubin (TBIL) (r = 0.592), and a weak correlation with model for end-stage liver disease score (r = 0.483) and international normalized ratio (r = 0.389). The AUCROC and optimum thresholds of PCT and for predicting bacterial infections at different levels of TBIL were 0.907 (95% CI 0.828–0.958) and 0.38 ng/mL, respectively, for TBIL <5 mg/dL, 0.927 (95% CI 0.844–0.974) and 0.54 ng/mL (5 mg/dL ≤TBIL<10 mg/dL), 0.914 (95% CI 0.820–0.968) and 0.61 ng/mL (10 mg/dL ≤TBIL<20 mg/dL), 0.906 (95% CI 0.826–0.958) and 0.94 ng/mL (TBIL ≥20 mg/dL), respectively. This study demonstrated that PCT was a valuable marker of bacterial infection in patients with chronic liver diseases. TBIL affected PCT threshold, so different cut-offs should be used according to different TBIL values.
format Online
Article
Text
id pubmed-5265836
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-52658362017-02-03 Impact of hepatic function on serum procalcitonin for the diagnosis of bacterial infections in patients with chronic liver disease: A retrospective analysis of 324 cases Qu, Junyan Feng, Ping Luo, Yan Lü, Xiaoju Medicine (Baltimore) 4900 Although procalcitonin (PCT) is a valid marker for early diagnosis of bacterial infections, it is unclear whether its accuracy in predicting bacterial infections is affected by impaired liver function. This study aimed to assess the impact of compromised liver function on the diagnostic value of PCT. This retrospective study was conducted between January 2013 and May 2015. A total of 324 patients with chronic liver disease were enrolled. Routine laboratory measurements and PCT were performed. Patients were divided into 3 groups according to clinical diagnosis: chronic hepatitis (group 1), decompensated cirrhosis (group 2), and acute-on-chronic liver failure/chronic liver failure (group 3). The correlation between PCT and liver function was analyzed. The area under the receiver operating characteristic (AUCROC) curve of PCT was analyzed according to infection status and liver function. PCT was more accurate than white blood cell count (P < 0.001) and percentage of neutrophils (P < 0.001) in detecting bacterial infections in patients with impaired liver function. In patients without infection, PCT had a moderate positive correlation with serum total bilirubin (TBIL) (r = 0.592), and a weak correlation with model for end-stage liver disease score (r = 0.483) and international normalized ratio (r = 0.389). The AUCROC and optimum thresholds of PCT and for predicting bacterial infections at different levels of TBIL were 0.907 (95% CI 0.828–0.958) and 0.38 ng/mL, respectively, for TBIL <5 mg/dL, 0.927 (95% CI 0.844–0.974) and 0.54 ng/mL (5 mg/dL ≤TBIL<10 mg/dL), 0.914 (95% CI 0.820–0.968) and 0.61 ng/mL (10 mg/dL ≤TBIL<20 mg/dL), 0.906 (95% CI 0.826–0.958) and 0.94 ng/mL (TBIL ≥20 mg/dL), respectively. This study demonstrated that PCT was a valuable marker of bacterial infection in patients with chronic liver diseases. TBIL affected PCT threshold, so different cut-offs should be used according to different TBIL values. Wolters Kluwer Health 2016-07-29 /pmc/articles/PMC5265836/ /pubmed/27472699 http://dx.doi.org/10.1097/MD.0000000000004270 Text en Copyright © 2016 the Author(s). Published by Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 4900
Qu, Junyan
Feng, Ping
Luo, Yan
Lü, Xiaoju
Impact of hepatic function on serum procalcitonin for the diagnosis of bacterial infections in patients with chronic liver disease: A retrospective analysis of 324 cases
title Impact of hepatic function on serum procalcitonin for the diagnosis of bacterial infections in patients with chronic liver disease: A retrospective analysis of 324 cases
title_full Impact of hepatic function on serum procalcitonin for the diagnosis of bacterial infections in patients with chronic liver disease: A retrospective analysis of 324 cases
title_fullStr Impact of hepatic function on serum procalcitonin for the diagnosis of bacterial infections in patients with chronic liver disease: A retrospective analysis of 324 cases
title_full_unstemmed Impact of hepatic function on serum procalcitonin for the diagnosis of bacterial infections in patients with chronic liver disease: A retrospective analysis of 324 cases
title_short Impact of hepatic function on serum procalcitonin for the diagnosis of bacterial infections in patients with chronic liver disease: A retrospective analysis of 324 cases
title_sort impact of hepatic function on serum procalcitonin for the diagnosis of bacterial infections in patients with chronic liver disease: a retrospective analysis of 324 cases
topic 4900
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5265836/
https://www.ncbi.nlm.nih.gov/pubmed/27472699
http://dx.doi.org/10.1097/MD.0000000000004270
work_keys_str_mv AT qujunyan impactofhepaticfunctiononserumprocalcitoninforthediagnosisofbacterialinfectionsinpatientswithchronicliverdiseasearetrospectiveanalysisof324cases
AT fengping impactofhepaticfunctiononserumprocalcitoninforthediagnosisofbacterialinfectionsinpatientswithchronicliverdiseasearetrospectiveanalysisof324cases
AT luoyan impactofhepaticfunctiononserumprocalcitoninforthediagnosisofbacterialinfectionsinpatientswithchronicliverdiseasearetrospectiveanalysisof324cases
AT luxiaoju impactofhepaticfunctiononserumprocalcitoninforthediagnosisofbacterialinfectionsinpatientswithchronicliverdiseasearetrospectiveanalysisof324cases